Reference
Balaban DY, et al. Private Expenditures on Brand Name Prescription Drugs after Generic Entry. Applied Health Economics and Health Policy : 27 Aug 2013. Available from: URL: http://dx.doi.org/0.1007/s40258-013-0052-y
Rights and permissions
About this article
Cite this article
Savings from use of generics could be much higher. PharmacoEcon Outcomes News 686, 8 (2013). https://doi.org/10.1007/s40274-013-0689-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0689-7